Cargando…
The immuno-behavioural covariation associated with the treatment response to bumetanide in young children with autism spectrum disorder
Bumetanide, a drug being studied in autism spectrum disorder (ASD) may act to restore gamma-aminobutyric acid (GABA) function, which may be modulated by the immune system. However, the interaction between bumetanide and the immune system remains unclear. Seventy-nine children with ASD were analysed...
Autores principales: | Li, Qingyang, Zhang, Lingli, Shan, Haidi, Yu, Juehua, Dai, Yuan, He, Hua, Li, Wei-Guang, Langley, Christelle, Sahakian, Barbara J., Yao, Yin, Luo, Qiang, Li, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166783/ https://www.ncbi.nlm.nih.gov/pubmed/35660740 http://dx.doi.org/10.1038/s41398-022-01987-x |
Ejemplares similares
-
Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios
por: Zhang, Lingli, et al.
Publicado: (2020) -
Correction: Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios
por: Zhang, Lingli, et al.
Publicado: (2020) -
Nanoformulated Bumetanide Ameliorates Social Deficiency in BTBR Mice Model of Autism Spectrum Disorder
por: Lv, Hui, et al.
Publicado: (2022) -
Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
por: Lemonnier, E, et al.
Publicado: (2017) -
Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
por: Lemonnier, E, et al.
Publicado: (2017)